anthranilic acid has been researched along with 3-(3,4-dimethoxyphenyl)propenoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astola, N; Cole, JE; Cribbs, AP; Davies, AH; Feldmann, M; Goddard, ME; Green, P; Monaco, C; Park, I; Williams, RO | 1 |
1 other study(ies) available for anthranilic acid and 3-(3,4-dimethoxyphenyl)propenoic acid
Article | Year |
---|---|
Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cinnamates; Drug Design; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mice; Mice, Knockout; ortho-Aminobenzoates; Real-Time Polymerase Chain Reaction | 2015 |